dermatan sulfate has been researched along with rivaroxaban in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Babuty, A; Boissier, E; Fouassier, M; Gouin-Thibault, I; Lakhal, K; Roussel, JC; Rozec, B; Senage, T; Sigaud, M; Ternisien, C; Trossaert, M | 1 |
1 other study(ies) available for dermatan sulfate and rivaroxaban
Article | Year |
---|---|
Heparin Anti-Xa Activity, a Readily Available Unique Test to Quantify Apixaban, Rivaroxaban, Fondaparinux, and Danaparoid Levels.
Topics: Blood Coagulation; Blood Coagulation Tests; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Factor Xa Inhibitors; Fondaparinux; France; Heparitin Sulfate; Humans; Predictive Value of Tests; Pyrazoles; Pyridones; Reproducibility of Results; Retrospective Studies; Rivaroxaban | 2021 |